Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 21 - Number 2

Review Article (Mini-Review)

Modulation of Matrix Metalloproteinases by Plant-derived Products

, 21(2): 91 - 106

Nur Najmi Mohamad Anuar*, Nurul Iman Natasya Zulkafali and Azizah Ugusman

DOI: 10.2174/1568009620666201120144838

Review Article

Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective

, 21(2): 107 - 116

Fabio Campodonico*, Marco Ennas, Silvia Zanardi , Ekaterini Zigoura, Arnoldo Piccardo, Luca Foppiani, Concetta Schiavone, Lino Squillace, Andrea Benelli, Andrea De Censi , Filippo Grillo-Ruggieri and Carlo Introini

DOI: 10.2174/1568009620666201021163919

Review Article

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

, 21(2): 117 - 131

Wenjun Wang, Ling Bai, Dongsheng Xu, Wei Li and Jiuwei Cui*

DOI: 10.2174/1568009620666200504111914

Review Article

MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy

, 21(2): 132 - 152

Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair and Lekshmi. R. Nath*

DOI: 10.2174/1568009620666201116113334

Review Article

Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer

, 21(2): 153 - 162

Acharya Balkrishna, Rashmi Mittal and Vedpriya Arya*

DOI: 10.2174/1568009620999201103201626

Research Article

Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients

, 21(2): 163 - 176

Uzma Karamat and Samina Ejaz*

DOI: 10.2174/1568009620666201009125507


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog